Rogers et al suggested adjuvant therapy, but it had not been supported by large studies or guidelines.
Bedoya A, Glisinski K, Clarke J, Lind RN, Buckley CE, Shofer S. Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Center Experience of Two Cases. Am J Case Rep. 2017;18:842846. Published 2017 Jul 31. doi:10.12659/ajcr.904416
Rogers DJ, Ojha S, Maurer R, Hartnick CJ. Use of Adjuvant Intralesional Bevacizumab for Aggressive Respiratory Papillomatosis in Children. JAMA Otolaryngol Head Neck Surg. 2013;139(5):496501. doi:10.1001/jamaoto.2013.1810